Exploring the contribution of estrogen to amyloid-beta regulation:a novel multifactorial computational modeling approach
According to the amyloid hypothesis, Alzheimer Disease results from the accumulation beyond normative levels of the peptide amyloid-β (Aβ). Perhaps because of its pathological potential, Aβ and the enzymes that produce it are heavily regulated by the molecular interactions occurring within cells, in...
Main Author: | Thomas J. Anastasio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00016/full |
Similar Items
-
Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity
by: Oh Young Bang, et al.
Published: (2004-06-01) -
The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
by: Xue-mei Qi, et al.
Published: (2017-08-01) -
Beta-amyloid oligomers: recent developments
by: Borutaite Vilmante, et al.
Published: (2011-06-01) -
Results of Beta Secretase-Inhibitor Clinical Trials Support Amyloid Precursor Protein-Independent Generation of Beta Amyloid in Sporadic Alzheimer’s Disease
by: Vladimir Volloch, et al.
Published: (2018-06-01) -
Enhanced expression of ERα in astrocytes modifies the response of cortical neurons to β-amyloid toxicity
by: Viviana Carbonaro, et al.
Published: (2009-03-01)